Akebia Therapeutics Inc (AKBA) Q1 2020 earnings call dated May 05, 2020 Corporate Participants: Kristen Sheppard -- Vice President, Investor Relations John Butler -- President and
Akebia Therapeutics Inc.
-(AKBA)
XNAS:AKBA
Akebia Therapeutics (AKBA) Q4 2019 Earnings Snapshot
-- Akebia Therapeutics (NASDAQ: AKBA) reported fourth quarter 2019 loss of $0.79 per share vs. expected loss of $0.47 per share. --